BioSpace News Archive

GE Healthcare and Optellum announced that they have signed a letter of intent to collaborate to advance precision diagnosis and treatment of lung cancer.

Theratechnologies Inc., a biopharmaceutical company focused on the development and commercialization of innovative therapies, is pleased to announce that it was awarded of the 2021 Innovation Award in the “Life Sciences” category at the 31st ADRIQ Innovation Awards Gala held on November 25, 2021.

Akero Therapeutics, Inc., a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, announced that management will participate in a fireside chat at the Evercore ISI 4th Annual HealthCONx Virtual Conference on Thursday December 2 at 3:30 p.m. E.T.

StageZero Life Sciences, Ltd. is pleased to announce that it has closed its previously announced private placement of its common shares and warrants to purchase Common Shares with institutional investors for gross proceeds of approximately CAD$4.2 million.

Public health authorities in South Africa have confirmed that a new COVID-19 variant of concern has been detected in that country.

Orexo AB, provides information about its new proprietary drug delivery platform, amorphOXTM, a novel and inventive powder-based technology with significant potential.

Immunovia AB announces that Tobias Bülow has been appointed new Senior Director Investor Relations and Corporate Communications, taking up his position January 15.

Vitrolife AB publishes a prospectus for the admission to trading of newly issued shares in Vitrolife on Nasdaq Stockholm’s main market in connection with a non-cash issue through which Vitrolife acquires all shares in Mendel Holdco S.L. and thereby indirectly all shares in Igenomix S.L.

Merck Canada is proud to announce that the Kingston Health Sciences Centre, first place winner of the Lung Cancer Innovation Challenge, has launched a Lung Diagnostic Assessment Program at the Lennox & Addington County General Hospital in Napanee, Ontario.

QIAGEN N.V. announced its polymerase chain reaction tests remain accurate and effective in detecting SARS-CoV-2 infections in light of the emergence of a new variant of concern detected in South Africa.